6 results
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology #
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... are contacts of infectious ... isolate DST result should ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... CMV retinitis should ... should include ... #management #opportunistic ... #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
on MRA/CTA • Anterior ... Diagnosis: • Infection ... count in the CSF should ... Syndrome #diagnosis #management ... #neurology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
should be initiated ... below for TB drug dosing ... Guidelines for dosing ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
to Table 5 for dosing ... Note: Active TB should ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology